FDA R*jects P*tential PTSD Tr*atment

The U.S. Food and Drug Administration (FDA) declined to approve MDMA, commonly known as ecstasy, as a treatment for post-traumatic stress disorder (PTSD).

“Drugmaker Lykos Therapeutics had asked the FDA to approve its MDMA capsules as part of a therapy regimen they argued could be a breakthrough for treating challenging